Loading clinical trials...
Loading clinical trials...
The goal of this study is to learn how injection drug use may affect the immune system.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rockefeller University
NCT05739071 · Lower Urinary Tract Symptoms, Intravenous Drug Usage, and more
NCT05657106 · Opioid-Related Disorders, Hepatitis C (HCV), and more
NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage
NCT03523533 · Intravenous Drug Usage
NCT04943432 · Intravenous Drug Usage
The Rockfeller University
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions